Clinical Trial Update: Effects of Abatacept on Myocarditis in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial investigating abatacept for myocarditis in rheumatoid arthritis was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocarditis
• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: Columbia University | Conditions: Rheumatoid Arthritis, Myocardial Inflammation | Phase 4 | Status: TERMINATED | Results posted: 2023-05-08